CYP1A inhibitors: Recent progress, current challenges, and future perspectives

Area of Science:

• Biochemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Mammalian cytochrome P450 1A (CYP1A) enzymes are crucial for metabolizing xenobiotics, drugs, and endogenous compounds.
• The human CYP1A subfamily (hCYP1A1 and hCYP1A2) activates environmental procarcinogens into carcinogenic forms.
• CYP1A inhibitors are explored for cancer chemoprevention and managing drug toxicity/resistance.

Purpose of the Study:

• To review recent advancements in the discovery and characterization of human CYP1A (hCYP1A) inhibitors.
• To analyze structural features, structure-activity relationships, and biomedical applications of hCYP1A inhibitors.
• To identify challenges and future directions in hCYP1A inhibitor research.

Main Methods:

• Comprehensive summary of reported hCYP1A inhibitors, including inhibition potentials, modes, and constants.
• In-depth analysis of structural features and structure-activity relationships for hCYP1A1 and hCYP1A2 inhibitors.
• Review of discovery approaches and biomedical applications.

Main Results:

• Detailed summary of inhibition data for various hCYP1A inhibitors.
• Analysis of structure-activity relationships for different classes of hCYP1A1 and hCYP1A2 inhibitors.
• Identification of key structural determinants for inhibitory activity.

Conclusions:

• hCYP1A inhibitors represent a promising therapeutic strategy for cancer chemoprevention and overcoming drug resistance.
• Further research into hCYP1A inhibitors will facilitate the development of effective chemo-preventive agents and research tools.
• This review provides valuable insights for researchers in the field of CYP1A inhibitor discovery and development.